U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Quotables

"I hate what they've done to my child...I would never let my own children watch it. "

Vladimir Zworykin, television pioneer ; Talking about an invention in which he played a critical role.

Newsletter  PatentStorm News

Make the Most of PatentStorm

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest patents by subscribing to an RSS feed.

Got questions? Ask a Patent Expert!

Registered users: Manage your profile, comments and alerts.

 

US Patent 6984403 - Azithromycin dosage forms with reduced side effects

US Patent Issued on January 10, 2006
Estimated Patent Expiration Date: Icon_subject January 23, 2024Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
loading...


View Patent Images (PDF)
(Registered users only)

Abstract

The present invention is related to an oral dosage form comprising an effective amount of an alkalizing agent and an azithromycin multiparticulate wherein said multiparticulate comprises azithromycin, a glyceride which comprises glyceryl monobehenate, glyceryl dibehenate, glyceryl tribehenate, or a mixture thereof and a poloxamer. Typically, the oral dosage form includes any suitable oral dosing means such as a powder for oral suspension, a unit dose packet or sachet, a tablet or a capsule.

Other References

  • Foulds, G., et al., “The effects of an antacid or cimetidine on the serum concentrations of azithromycin”, J. Clin. Pharmacol. 1991 Feb.; 31(2): 164-7 (Abstract).
  • Amsden, G.W., et al., “Serum and WBC pharmacokinetics of 1500 mg of azithromycin when given either as a single dose or over a 3 day period in healthy volunteers”, J. Antimicrobial Chemotherapy (2001), 47(1), 61-66 (Abstract).
  • Barber, J., “Assignments of the 13C and 1H NMR Spectra of Azithromycin in CDCI3,” Magnetic Resonance in Chemistry 29:7(1991)740-743.
  • Barthelemy, P., et al., “Compritol® 888 ATO: An Innovative Hot-Melt Coating Agent for Prolonged-Release Drug Formulations,” Europ. J. Pharmaceut. and Biopharmaceutics, 47(1999)87-90.
  • Bhagwatwar, H., et al., “Preparation of Drug-Containing Wax Microspheres Using a Melt Dispersion Technique,” Pharmaceutical Research, 6:7(1989)S-177, Abstract No. PD 1201.
  • Breitenbach, J., et al., “Solid Dispersions by an Integrated Melt Extrusion System,” Proceed. Int'l Symp. Control Re. Bioact. Materials, 25(1998)804-805.
  • Craig, D.Q.M., “The Physical Characterisation of Gelucire 50/13,” Bulletin Technique Gattefosse, 89(1996)39-51.
  • DeMan, J.M., et al., “Thermal Analysis Microscopy for the Study of Phase Changes in Fats,” Food Microstructure, 4(1985)233-239.
  • Eldem T., et al., “Polymorphic Behavior of Sprayed Lipid Micropellets and its Evaluation by Differential Scanning Calorimetry and Scanning Electron Microscopy,” Pharmaceutical Research, 8:2(1991)178-184.
  • Eldern, T., et al., “Optimization of Spray-Dried and -Congealed Lipid Micropellets and Characterization of Their Surface Morphology by Scanning Electron Microscopy,” Pharmaceutical Research, 8:1(1991)47-54.
  • Emas, M., and H. Nyqvist, “Methods of Studying Aging and Stabilization of Spray-Congealed Solid Dispersions with Carnauba Wax. 1. Microcalorimetric Investigation,” Int'l J. Pharmaceutics, 197(2000)117-127.
  • Faham, A., et al., “Hot-Melt Coating Technology. I. Influence of Compritol 888 Ato and Granule Size on Theophyline Release,” Drug Dev. Industrial Pharm., 26:2(2000)167-176.
  • Follonier, N., et al, “Hot-Melt Extruded Pellets for the Sustained Release of Highly Dosed Freely Soluble Drugs,” Proceed. Intern. Symp. Control. Release Bioactive Materials, 18(1991)578-579.
  • Forster, A., et al., “Characterization of Glass Solutions of Poorly Water-Soluble Drugs Produced by Melt Extrusion with Hydrophific Amorphous Polymers, ” J. Pharmacy Pharmacology, 53(2001)303-315.
  • Foulds, G., et al., “The Absence of an Effect of Food on the Bioavailability of Azithromycin Administered as Tablets, Sachet or Suspension,” J. Antimicrobial Chemotherapy, 37:Suppl. C(1996)37-44.
  • Gattefosse, “Gelucire®—Pharmaceutical Excipients for Oral Semi-Solid Formulations,” Technical Dossler, 2nd edition, Gattefosse s.a., Cedex, France (1996).
  • Ghali, E.S., et al., “Thermal Treatment of Beads with Wax for Controlled Release,” Drug Development and Industrial Pharmacy, 15:9(1989)1311-1328.
  • Hancock, B.C., and G. Zografi, “The Relationship Between the Glass Transition Temperature and the Water Content of Amorphous Pharmaceutical Solids,” Pharmaceutical Research, 11:4(1994)471-477.
  • Joachim, J., et al., “Le Compritol”, Etudes Galenique, Physique et Statstique, APGI, IV(1989)291-296.
  • Johnson, D.E., et al., “A New Method for Coating Glass Beads for Use in Gas Chromatography of Chloropromazine and its Metabolites,” Source unknown, and date unknown. (may be 1964-1965).
  • Jorgensen, K., et al., “Dissolution Stability of Multiparticulate Controlled Release Tablets,” Int'l J. Pharmaceutics, 153(1997)1-11.
  • Meshall, M.M., et al., “Optimization of Theophylline Release from Tablets Containing Compritol,” S.T.P. Pharma Sciences, 5:6(1995)429-434.
  • Perez, M. deLos A, et al., “Sustained Release Phenylpropanolamine Hydrochloride from Compritol ATO-888 Matrix,” Pharmaceutical Research, 9:10(1992)S-162, Abstract No. PT6191.
  • Perez, M.A., et al., “Sustained Release Phenylpropanolamine Hydrochloride from ATO 888 Matrix,” PRHSJ, 12:4(1993)263-267.
  • Perissutti, B., et al., “Solid Dispersions of Carbamazepine with Gelucire 44/14 and 50/13,” S.T.P. Pharma Sciences, 10:6(2000)479-484.
  • Physician's Desk Reference, Information cited on ZITHROMAX® capsules (equivalent to 250 mg azithromycin), tablets (equivalent to 600 mg azithromycin), and oral suspension (equivalent to 1g azithromycin).
  • Reilly, W.J. Jr., and J.B. Schwartz, “A Potential Controlled Release Wax Matrix Excipient,” Pharmaceutical Research, 8:10(1991)98, supplement, Abstract No. TP6108.
  • Reis, R. and F. Moll, “Matrix Formation of Polyglycolic Acid Tablets by Annealing,” European J. Pharm. and Biopharm., 40:1(1994)14-18.
  • Rxlist.com, “Azithromycin,” description of drug, categories, brand names, from internet website, Mar. 14, 2001.
  • San Vincente, A., et al., “Effect of Aging on the Release of Salbutamol Sulfate from Lipid Matrices,” Int'l J. Pharmaceutics, 208(2000)13-21).
  • Schwartz, J.B., et al., “A Potential Controlled Release Wax Matrix Excipient for Tablets,” Pharmaceutical Research, 9:10(1992)S-162, Abstract No. PT6189.
  • Schwartz, J.B., et al., Preliminary Evaluation of Controlled Release Agents for Tablets, Pharmaceutical Research, 9:10(1992)S-162, Abstract No. PT6190.
  • Sugao, H., et al, “Taste Masking of Bitter Drug Powder without Loss of Bioavailability by Heat Treatment of Wax-Coated Microparticles,” J. Pharmaceutical Sci., 87:1(1998)96-100.
  • Thomasen, L.J., et al., “Prolonged Release Matrix Pellets Prepared by Melt Pelletization. I. Process Variables,” Drug Development and Industrial Pharmacy, 19:15(1993)187-1887.
  • Wang, A.E. and J.B. Schwartz, “Effect of Temperature on Drug Release from Wax Matrix Tablets After Thermal Treatment,” Pharmaceutical Research, 11:10(1994)S-155. Abstract No. 6099.
  • Zhang, Y.-E., et al., Effect of Processing Methods and Heat Treatment on the Formation of Wax Matrix Tablets for Sustained Drug Release, Pharm. Dev. Technol., 6:2(2001)131-144.
  • Arguendas, A., “Single Dose Therapy in Otitis Media, Clinical Microbiology and Infection,” Abstract, S130, vol. 5, Supplemental 3, (1999).
  • Block, S., et al., “Single-Dose Azithromycin (30 mg/kg) in Acute Otitis Media,” ICAAC, New Orleans, La, Sep. 7-10, 2003, Abstract 174.
  • Curatolo, W., et al., “Site-Specific Absorption and Toleration of Azithromycin,” Proceedings Intern. Symposium Rel. Bioact. Mater., 23, 1996.
  • Luke, D.R., et al, “Clinical Pharmacology of Azithromycin Given at Various Sites Along the Gastrointestinal Tract in Healthy Subjects,” pp. 464-468.
  • Physicians Desk Reference, “Appendix A Summary of Pediatric Suspension Commercial Products,” 55th edition, Phase III Clinical Dosage Form Nomination, pp 19 and 28 (2001).
  • Pfizer, Inc., Zithromax [package insert], “Zithromax (azithromycin tablets) and (azithromycin for oral suspension),” www.pfizer.com/download/uspi zithromax.pdf (2004).

Inventors

Assignee

Application

No. 10763340 filed on 01/23/2004

US Classes:

424/489, Particulate form (e.g., powders, granules, beads, microcapsules, and pellets)424/400, PREPARATIONS CHARACTERIZED BY SPECIAL PHYSICAL FORM424/464, Tablets, lozenges, or pills424/451Capsules (e.g., of gelatin, of chocolate, etc.)

Field of Search

424/490, Coated (e.g., microcapsules)424/489, Particulate form (e.g., powders, granules, beads, microcapsules, and pellets)424/464, Tablets, lozenges, or pills424/484, Matrices424/465, With claimed perfecting feature in contents (e.g., excipient, lubricant, etc.)424/400, PREPARATIONS CHARACTERIZED BY SPECIAL PHYSICAL FORM424/451Capsules (e.g., of gelatin, of chocolate, etc.)

Examiners

Primary: Page, Thurman K.
Assistant: Hawes, Pili A.

Attorney, Agent or Firm

US Patent References

2955956, 4053264, Apparatus for making metal powder
Issued on: 10/11/1977
Inventor: King
4086346, Preparation of melt-sprayed spherical phenacetin granules
Issued on: 04/25/1978
Inventor: Bocker, et al.
4092089, Apparatus for the preparation of melt-sprayed spherical phenacetin granules
Issued on: 05/30/1978
Inventor: Bocker, et al.
4293570, Process for the preparation of sweetener containing product
Issued on: 10/06/1981
Inventor: Vadasz
4474768, N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
Issued on: 10/02/1984
Inventor: Bright
4517359, 11-Methyl-11-aza-4-0-cladinosyl-6-0-desosaminyl-15-ethyl-7,1 3,14-trihydroxy-3,5,7,9,12,14-hexamethyl-oxacyclopentadecane-2-one and derivatives thereof
Issued on: 05/14/1985
Inventor: Kobrehel ,   et al.
4675140, Method for coating particles or liquid droplets
Issued on: 06/23/1987
Inventor: Sparks ,   et al.
4874611, Microencapsulated ant bait
Issued on: 10/17/1989
Inventor: Wilson, et al.
4931285, Aqueous based pharmaceutical coating composition for dosage forms
Issued on: 06/05/1990
Inventor: Edgren, et al.
4957681, Preparation of pharmaceutical mixtures
Issued on: 09/18/1990
Inventor: Klimesch, et al.
4963531, Azithromycin and derivatives as antiprotozoal agents
Issued on: 10/16/1990
Inventor: Remington
5019302, Method for granulation
Issued on: 05/28/1991
Inventor: Sparks, et al.
5024842, Annealed coats
Issued on: 06/18/1991
Inventor: Edgren, et al.
5047244, Mucoadhesive carrier for delivery of therapeutical agent
Issued on: 09/10/1991
Inventor: Sanvordeker, et al.
5064650, Controlled-release salt sensitive capsule for oral use and adhesive system
Issued on: 11/12/1991
Inventor: Lew
5084287, Pharmaceutically useful micropellets with a drug-coated core and controlled-release polymeric coat
Issued on: 01/28/1992
Inventor: Ghebre-Sellassie, et al.
5100592, Method and apparatus for granulation and granulated product
Issued on: 03/31/1992
Inventor: Sparks, et al.
5143662, Process for preparing particles of bioabsorbable polymer
Issued on: 09/01/1992
Inventor: Chesterfield, et al.
5160743, Annealed composition for pharmaceutically acceptable drug
Issued on: 11/03/1992
Inventor: Edgren, et al.
5169645, Directly compressible granules having improved flow properties
Issued on: 12/08/1992
Inventor: Shukla, et al.
5183690, Starch encapsulation of biologically active agents by a continuous process
Issued on: 02/02/1993
Inventor: Carr, et al.
5194262, Encapsulated antiperspirant salts and deodorant/antiperspirants
Issued on: 03/16/1993
Inventor: Goldberg, et al.
5196199, Hydrophilic form of perfluoro compounds and method of manufacture
Issued on: 03/23/1993
Inventor: Fuisz
5213810, Stable compositions for parenteral administration and method of making same
Issued on: 05/25/1993
Inventor: Steber
5236734, 5292657, Process for preparing rotary disc fatty acid microspheres of microorganisms
Issued on: 03/08/1994
Inventor: Rutherford, et al.
5348758, Controlled melting point matrix formed with admixtures of a shearform matrix material and an oleaginous material
Issued on: 09/20/1994
Inventor: Fuisz, et al.
5380473, Process for making shearform matrix
Issued on: 01/10/1995
Inventor: Bogue, et al.
5405617, Aliphatic or fatty acid esters as a solventless carrier for pharmaceuticals
Issued on: 04/11/1995
Inventor: Gowan, Jr., et al.
5407676, Hydrophilic form of perfluoro compounds and a method of manufacture
Issued on: 04/18/1995
Inventor: Fuisz
5429836, Saccharide-based matrix
Issued on: 07/04/1995
Inventor: Fuisz
5433951, Sustained release formulation containing captopril and method
Issued on: 07/18/1995
Inventor: Serajuddin, et al.
5456932, Method of converting a feedstock to a shearform product and product thereof
Issued on: 10/10/1995
Inventor: Fuisz, et al.
5461089, Powder coating compositions and process for the manufacture thereof
Issued on: 10/24/1995
Inventor: Handyside, et al.
5500162, Process and device for producing microspheres
Issued on: 03/19/1996
Inventor: Theisen, et al.
5501858, Rapidly dispersable compositions containing polydextrose
Issued on: 03/26/1996
Inventor: Fuisz
5505983, Spherical seed cores, spherical granules and process for production thereof
Issued on: 04/09/1996
Inventor: Kamada
5518730, Biodegradable controlled release flash flow melt-spun delivery system
Issued on: 05/21/1996
Inventor: Fuisz
5539000, Spray-chilled nabumetone
Issued on: 07/23/1996
Inventor: Leonard
5549917, Flash flow formed solloid delivery systems
Issued on: 08/27/1996
Inventor: Cherukuri, et al.
5556652, Comestibles containing stabilized highly odorous flavor component delivery systems
Issued on: 09/17/1996
Inventor: Cherukuri, et al.
5569467, Process for the preparation of microballs and microballs thus obtained
Issued on: 10/29/1996
Inventor: Ruiz
5582855, Flash flow formed solloid delivery systems
Issued on: 12/10/1996
Inventor: Cherukuri, et al.
5597416, Method of making crystalline sugar and products resulting therefrom
Issued on: 01/28/1997
Inventor: Fuisz, et al.
5597844, Cimetidine granules coated with a partially hydrogenated vegetable oil
Issued on: 01/28/1997
Inventor: Chauhan, et al.
5601761, Encapsulated active materials and method for preparing same
Issued on: 02/11/1997
Inventor: Hoffman, et al.
5605889, Method of administering azithromycin
Issued on: 02/25/1997
Inventor: Curatolo, et al.
5633006, Taste-masking composition of bitter pharmaceutical agents
Issued on: 05/27/1997
Inventor: Catania, et al.
5683720, Liquiflash particles and method of making same
Issued on: 11/04/1997
Inventor: Myers, et al.
5690959, Pharmaceutical thermal infusion process
Issued on: 11/25/1997
Inventor: Palepu, et al.
5705190, Controlled release formulation for poorly soluble basic drugs
Issued on: 01/06/1998
Inventor: Broad, et al.
5707646, Taste masking pharmaceutical composition
Issued on: 01/13/1998
Inventor: Yajima, et al.
5733577, Delivery of controlled-release system (s)
Issued on: 03/31/1998
Inventor: Myers, et al.
5741519, The production of active substance compositions in the form of a solid solution of the active substance in a polymer matrix, and active substance compositions produced by this process
Issued on: 04/21/1998
Inventor: Rosenberg, et al.
5744180, 5747058, High viscosity liquid controlled delivery system
Issued on: 05/05/1998
Inventor: Tipton, et al.
5766521, Process for obtaining cristallized pearls exhibiting the phenomenon of supercooling
Issued on: 06/16/1998
Inventor: Le Thiesse, et al.
5792474, Process for the production of retarded pharmaceutical compositions
Issued on: 08/11/1998
Inventor: Rauchfuss
5824342, Flash flow formed solloid delivery systems
Issued on: 10/20/1998
Inventor: Cherukuri, et al.
5840334, Self-binding shearform compositions
Issued on: 11/24/1998
Inventor: Raiden, et al.
5849223, Liquiflash particles and method of making same
Issued on: 12/15/1998
Inventor: Myers, et al.
5851553, Process and apparatus for making rapidly dissolving dosage units and product therefrom
Issued on: 12/22/1998
Inventor: Myers, et al.
5851555, Controlled release dosage forms containing water soluble drugs
Issued on: 12/22/1998
Inventor: Sanghvi, et al.
5855915, Tablets or biologically acceptable implants for long-term antiinflammatory drug release
Issued on: 01/05/1999
Inventor: Pinkus
5869098, Fast-dissolving comestible units formed under high-speed/high-pressure conditions
Issued on: 02/09/1999
Inventor: Misra, et al.
5869101, Process for the preparation of S(+)-ibuprofen-particles
Issued on: 02/09/1999
Inventor: Moller, et al.
5883103, Oral acyclovir delivery
Issued on: 03/16/1999
Inventor: Burnside, et al.
5891845, Drug delivery systems utilizing liquid crystal structures
Issued on: 04/06/1999
Inventor: Myers
5912030, Comestible products having extended release of addititives and method of making
Issued on: 06/15/1999
Inventor: Huzinec, et al.
5919489, Process for aqueous granulation of clarithromycin
Issued on: 07/06/1999
Inventor: Saleki-Gerhardt, et al.
5935600, Process for forming chewable quickly dispersing comestible unit and product therefrom
Issued on: 08/10/1999
Inventor: Cherukuri, et al.
5948407, Oral induction of tolerance to parenterally administered non-autologous polypeptides
Issued on: 09/07/1999
Inventor: McGuinness, et al.
5952004, Emulsified drug delivery systems
Issued on: 09/14/1999
Inventor: Rudnic, et al.
5958452, Extruded orally administrable opioid formulations
Issued on: 09/28/1999
Inventor: Oshlack, et al.
5965161, Extruded multi-particulates
Issued on: 10/12/1999
Inventor: Oshlack, et al.
5965164, Recipient-dosage delivery system
Issued on: 10/12/1999
Inventor: Fuisz, et al.
5972373, Taste masking pharmaceutical composition for oral administration
Issued on: 10/26/1999
Inventor: Yajima, et al.
5980941, Self-binding shearform compositions
Issued on: 11/09/1999
Inventor: Raiden, et al.
6010718, Extended release formulations of erythromycin derivatives
Issued on: 01/04/2000
Inventor: Al-Razzak, et al.
6013280, Immediate release dosage forms containing microspheres
Issued on: 01/11/2000
Inventor: Frisbee, et al.
6048541, Fast-dissolving comestible units formed under high-speed/high-pressure conditions
Issued on: 04/11/2000
Inventor: Misra, et al.
6051253, Production of solid drug forms
Issued on: 04/18/2000
Inventor: Zettler, et al.
6068859, Controlled-release dosage forms of Azithromycin
Issued on: 05/30/2000
Inventor: Curatolo, et al.
6077541, Omeprazole formulation
Issued on: 06/20/2000
Inventor: Chen, et al.
6083430, Method of preparing a dosage unit by direct tableting and product therefrom
Issued on: 07/04/2000
Inventor: Fuisz, et al.
6086920, Disintegratable microspheres
Issued on: 07/11/2000
Inventor: Frisbee, et al.
6090830, Controlled release compositions and methods for the treatment of hyperlipidemia
Issued on: 07/18/2000
Inventor: Myers, et al.
6103264, Process for preparing a controlled release composition
Issued on: 08/15/2000
Inventor: Hoffmann, et al.
6117452, Fatty ester combinations
Issued on: 09/12/2000
Inventor: Ahlgren, et al.
6139872, Method of producing a vitamin product
Issued on: 10/31/2000
Inventor: Walsh
6165512Dosage forms containing taste masked active agents
Issued on: 12/26/2000
Inventor: Mezaache, et al.

Foreign Patent References

  • 0080341 EP 06/01/1983
  • 0109253 EP 05/01/1984
  • 0582396 EP 02/01/1994
  • 0925789 EP 06/01/1999
  • 0943341 EP 09/01/1999
  • 0776658 EP 02/01/2000
  • 1127580 EP 08/01/2001
  • 2066070 GB 07/01/1981
  • 2091097 GB 07/01/1982
  • 187487 IN 05/01/2000
  • WO9107171 WO 05/01/1991
  • WO9400112 WO 01/01/1994
  • WO9427557 WO 12/01/1994
  • WO9509601 WO 04/01/1995
  • WO9806714 WO 02/01/1998
  • WO9818610 WO 05/01/1998
  • WO9846239 WO 10/01/1998
  • WO9856357 WO 12/01/1998
  • WO9903453 WO 01/01/1999
  • WO9924031 WO 05/01/1999
  • WO0026285 WO 05/01/2000
  • WO0057886 WO 10/01/2000
  • WO0142221 WO 06/01/2001
  • WO0178688 WO 10/01/2001
  • WO0185135 WO 11/01/2001
  • WO0224174 WO 03/01/2002
  • WO0318031 WO 03/01/2003
  • WO3032922 WO 04/01/2003
  • WO0337304 WO 05/01/2003
  • WO0353402 WO 07/01/2003
  • WO0383834 WO 08/01/2003
  • WO3068191 WO 08/01/2003
  • WO0400865 WO 12/01/2003
  • WO3105810 WO 12/01/2003
  • WO4009608 WO 01/01/2004
  • WO4035063 WO 04/01/2004
  • WO4087096 WO 10/01/2004

International Class

A61K 9/14

Comments

No comments for this page
 
 
Forgot password?
Register here